Renin angiotensin system inhibitors may attenuate low LDL cholesterol-related cancer risk in type 2 diabetes

Xilin Yang*, Ronald C.W. Ma, Wing Yee So, Ying Wang, Alice P.S. Kong, Risa Ozaki, Gang XU, Juliana C.N. Chan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Renin angiotensin system inhibitors may attenuate low LDL cholesterol-related cancer risk in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences